Gastroenterology Section:
Page 1-16, second column, Under Treatment of UC.
There is a discrepancy between the text in the second column and Table 1-3 regarding use of metronidazole in patients with fulminant UC. Although some physicians still use antibiotics in some cases, it has not been proven to be effective. For the Boards, metronidazole is not indicated in the treatment of mild-to-severe UC. It is indicated in the post-op Crohn patient because it helps prevent reanastomosis.

Page 1-29, first column, under ACUTE MESENTERIC ISCHEMIA.
"Bowel infarction leads to acidosis, increased SGOT (ALT), and elevated amylase." ALT should be replaced with AST.

Page 1-36, Table 1-9.
The heading of the 1st column should be HBsAg (without the Anti-), the heading for the 2nd column should be Anti-HBc, and the heading for the 3rd column should be Anti-HBs.

Infectious Disease Section: Page 2-21.
The references to "banana gametophyte" in the Quick Quiz box and in the text discussion of P. falciparum malaria should be "banana gametocyte."

Nephrology Section: Page 4-34, column 1, under "Pregnancy and Renal Disease."
The last sentence of the 2nd paragraph should read: "Screen all pregnant lupus patients for lupus anticoagulant (spontaneous abortion) and SSA/SSB antibodies (neonatal heart block).

General Internal Medicine Section: Page 10-6, column 2, paragraph 5.
A statement reads: "…it is very useful to use Table 10-5 in its stripped down form (Table 10-6)." The reference in the parentheses should be Table 10-7.

Cardiology Section:
Page 5-29; under PACEMAKERS, third paragraph. Corrected: "DDD stands for dual chambers paced, dual chambers sensed, and dual response to sensing: triggered  and inhibited."
 
Page 5-33, last line of first paragraph.
“Synthetic natriuretic peptide drugs are being developed to boost the vasoconstrictive, diuretic, and natriuretic effects of these peptides.” should read “Synthetic natriuretic peptid drugs are being developed to boost the vasodilatory, diuretic, and natriuretic effects of these peptides.”

Rheumatology Section: Page 6-12, column 2, end of 6th paragraph (regarding SLE).
It reads: "Anti-Ro/SSA antibody is also associated with a significant (10-20%) risk of neonatal lupus, which occasionally (10% of this number) causes congenital heart block. Replace with this: "Anti-Ro/SSA is also associated with a significant (10-20%) risk of neonatal lupus, which occasionally (10%) causes congenital heart block. Anti-La/SSB has also been associated with some cases of neonatal lupus, although not as rigorously associated as SSA."

Endocrinology Section:
Page 7-29; under subheading: "NORMAL CALCIUM PHYSIOLOGY; last line of first paragraph:
It reads: "PTH increases Ca+ from bone, increases renal tubular CA+ resorption, and renal tubular PO4 excretion." Replace this line with: "As mentioned above, PTH increases serum calcium levels by increasing resorption of bone and decreasing renal excretion of calcium. PTH stimulates renal secretion of phosphate which, in turn, enables calcium resorption."

Pulmonary Section:
Page 3-10, Table 3-2: "Treatment of Asthma based on Severity Category"
3) Moderate persistent category
Column FEV1 or PEF should read: > 60%, < 80%

Page 3-13, Second Column; sentence beginning: Criteria for starting continuous O₂.
Should read:

• resting P_aO₂ ≤ 55, or
• O₂sat (S_aO₂) ≤ 88%, or
• P_aO₂ ≤ 59 mm Hg (O₂sat ≤ 89%) with evidence of cor pulmonale or erythrocytosis (hematocrit > 55%).